"A human doctor saves the individual, a veterinarian saves mankind"
- Louis Pasteur
4766 – the enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of antibodies against the avian reovirus (REO)
In birds, viral arthritis and tenosynovitis are the most important pathological manifestations of avian reovirus infections. A malabsorption syndrome has also been associated with these infections, which manifests itself mainly by diarrhoea and osteoporosis.
Alongside chicks and turkey poults, reoviruses have also been isolated from other avian species: duck, pigeon, goose, psitacine birds, without determining any specific character of strict host. The transmission of reovirus infections can occur both horizontally and vertically.
There is no treatment for reovirus infections. Vaccination is used both with live vaccine and with inactivated vaccine. Vaccination of the parents provides protection by maternal antibodies to the offspring, even upon hatching. Active immunization is achieved by vaccination with live vaccine administered subcutaneously.
The serological exam seeks to detect the specific antibodies of the avian reovirus using ELISA immunoenzymatic techniques that meet the requirements of specificity and sensitivity.
gallinaceous bird blood serum
2 business days
quantitative determination of the antibodies against the avian reovirus from gallinaceous bird sera by way of the enzyme-linked immunosorbent ELISA assay, the indirect version